Valanbio Therapeutics Overview
- Founded
-
2015
- Status
-
Private
- Latest Deal Type
-
Angel
- Latest Deal Amount
-
$421K
Valanbio Therapeutics General Information
Description
Developer of anti-infective drugs created to cure various bacterial diseases. The company is currently operating in stealth mode.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Delivery
Primary Office
- 1120 Longstone Way
- Raleigh, NC 27614
- United States
+1 (919) 000-0000
Valanbio Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Angel (individual) | 14-Jan-2020 | $421K | 00000 | Completed | Stealth |
Valanbio Therapeutics Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Clayton Duncan | Chief Executive Officer & Board Member | ||
| Moise Khayrallah | Executive Officer & Board Member | ||
| Pei Zhou | Executive Officer & Board Member |
Valanbio Therapeutics Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| Clayton Duncan | Valanbio Therapeutics | Chief Executive Officer & Board Member | 000 0000 |
| Eric Toone | Valanbio Therapeutics | Board Member | 000 0000 |
| Moise Khayrallah | Valanbio Therapeutics | Executive Officer & Board Member | 000 0000 |
| Pei Zhou | Valanbio Therapeutics | Executive Officer & Board Member | 000 0000 |
| Sam Hopkins | Valanbio Therapeutics | Board Member | 000 0000 |